AC Immune SA announced that the shareholders of the company have elected Mr. Thomas Graney as a new member of the Board of Directors of the company at its Annual General Meeting held at EPFL Innovation Park, Lausanne. Mr. Graney serves as Chief Financial Officer and Senior Vice President of Finance & Corporate Strategy at Ironwood Pharmaceuticals Inc. Prior to Ironwood his professional career included 20 years with Johnson & Johnson and its affiliates, serving for four years as Worldwide Vice President of Finance and Chief Financial Officer of Ethicon. In addition, Mr. Graney has extensive global experience spanning corporate development, commercial strategy, portfolio management and supply chain management.